Moderna to collaborate with AbCellera
Partnership aims to develop mRNA-encoded antibody therapeutics
Read More
Tag: abcellera
Gilead, AbCellera team up against infectious diseases
AbCellera will receive upfront and research payments and is eligible to receive downstream clinical and commercial milestone payments and royalties.
Read More
AbCellera collaborates with Novartis for antibody discovery
AbCellera has announced a multi-target, multi-year deal with Novartis, to identify antibodies for ten therapeutic targets in Novartis’ pipeline, using a unique combination of microfluidics, high-throughput imaging, genomics, deep computing and AI.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
